In Vitro & In Vivo Diagnostic Substances
SIC 2835 · 22 companies
This page lists all SEC-registered public companies classified under SIC code 2835 (In Vitro & In Vivo Diagnostic Substances). SIC — Standard Industrial Classification — is a four-digit code system used by the SEC to group companies by their primary line of business. You can also view financial rankings for this industry.
The In Vitro & In Vivo Diagnostic Substances industry includes 22 SEC-registered public companies.
The largest by revenue is QuidelOrtho Corp,
which reported $2.7B in FY2025.
Companies in this industry with available XBRL data collectively reported $4.4B in revenue across their most recent fiscal years.
| Company | Ticker | Exchange | State | Filings |
|---|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | ACHV | NASDAQ | DE | 1,000 |
| Alpha Teknova, Inc. | TKNO | NASDAQ | DE | 205 |
| Anbio Biotechnology | NNNN | NASDAQ | E9 | 31 |
| Asep Medical Holdings Inc. | SEPSF | OTC | A1 | 8 |
| Aspira Women's Health Inc. | AWHL | OTC | DE | 1,000 |
| BIOMERICA INC | BMRA | NASDAQ | DE | 585 |
| BURZYNSKI RESEARCH INSTITUTE INC | BZYR | OTC | DE | 145 |
| Cardio Diagnostics Holdings, Inc. | CDIOW | NASDAQ | DE | 274 |
| Celldex Therapeutics, Inc. | CLDX | NASDAQ | DE | 1,002 |
| IDEXX LABORATORIES INC /DE | IDXX | NASDAQ | DE | 1,000 |
| IMMUCELL CORP /DE/ | ICCC | NASDAQ | DE | 766 |
| Insight Molecular Diagnostics Inc. | IMDX | NASDAQ | CA | 664 |
| Intellia Therapeutics, Inc. | NTLA | NASDAQ | DE | 683 |
| Lantheus Holdings, Inc. | LNTH | NASDAQ | DE | 1,000 |
| MYRIAD GENETICS INC | MYGN | NASDAQ | DE | 1,003 |
| NEOGEN CORP | NEOG | NASDAQ | MI | 1,000 |
| NYMOX PHARMACEUTICAL CORP | NYMXF | OTC | — | 402 |
| Q/C TECHNOLOGIES, INC. | QCLS | NASDAQ | DE | 582 |
| QuidelOrtho Corp | QDEL | NASDAQ | — | 435 |
| TRINITY BIOTECH PLC | TRIB | NASDAQ | L2 | 455 |
| VOLITIONRX LTD | VNRX | NYSE | DE | 1,000 |
| Virax Biolabs Group Ltd | VRAX | NASDAQ | E9 | 134 |